Research Education Component
研究教育部分
基本信息
- 批准号:10264194
- 负责人:
- 金额:$ 19.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-05 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Academic TrainingAddressAdvanced DevelopmentAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaArizonaBiological MarkersClinicalCollaborationsCommunitiesComplementDataData ScienceDiagnosisDiseaseEducation and OutreachEthicsFosteringFutureGoalsHispanic-serving InstitutionHispanicsHuman ResourcesLeadershipMentorshipMinorityModelingNational Institute of Neurological Disorders and StrokeNative AmericansNative-BornNeurodegenerative DisordersOccupational activity of managing financesOutcomePersonnel ManagementPersonsPopulation HeterogeneityPositioning AttributePostdoctoral FellowRecommendationReproducibilityResearchResearch PersonnelResourcesScienceTRADD geneTraining ProgramsTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of Healthblood-based biomarkercareercareer developmentclinically relevantcohortcollegeeducation researcheducational atmosphereexperiencefaculty researchfight againstfightinginnovationmultidisciplinarynext generationpersonalized strategiespre-doctoralpreclinical studypreventprogramsrate of changerecruitscience educationskill acquisitionskillssuccesssymposiumundergraduate researchundergraduate student
项目摘要
SUMMARY/ABSTRACT - RESEARCH EDUCATION COMPONENT (REC)
The Arizona ADRC REC training program addresses goals and objectives of the National Alzheimer's Project
Act (NACA) "To prevent and effectively treat Alzheimer's Disease and Related Dementias (AD/ADRD) by 2025.”
It is aligned with NIH AD and ADRD Research Summit recommendations, the ADRC's overarching theme (blood-
based biomarkers (“BBBs) in the diagnosis, preclinical study and prevention of AD/ADRD, its aggressively
collaborative model, and our commitment to help develop the next generation of AD/ADRD researchers,
including those from diverse backgrounds. We propose a personalized strategy to engage and advance junior
faculty and research associates to conduct innovative integrative AD/ADRD research that is clinically relevant,
translationally valid, scientifically reproducible and includes under-represented groups. To address gaps in
academic training, the AZ ADRC REC will advance the development of skills necessary to achieve success in
21st century team science, leadership, personnel and financial management and collaborative ethical research;
further develop and apply their expertise and skills in the fight against AD and ADRD; and capitalize on our
programs and Resource Center for Minority Aging Research (RCMAR) partnerships to advance research careers
and studies involving persons from Hispanic, Native American and other under-represented communities.
To build the pipeline of future AD/ ADRD researchers, we propose an experience dependent mentorship
strategy in which the AZ ADRC REC complements NIH / NIA training programs for postdoctoral, predoctoral and
undergraduate research fellows and spans ethnic, cultural and professional diversity. Strategies to achieve these
goals include: Specific Aim 1: Personalized AD/ADRD Research Career Plan for 21st Century Team Science;
Specific Aim 2: Leadership and Ethics at the Rate of Change in the 21st Century and Specific Aim 3: Building
the Alzheimer's Research Career Pipeline for the Future. Outcomes of these endeavors will advance the overall
ADRC goals articulated in the NIH/NIA Alzheimer's Disease Research Centers RFA-AG-20-004 including:
“Create a dynamic educational environment that supports disruptive and transformative research.
Accelerate translational research across the spectrum of disease.
Demonstrate scientifically productive interactions across NIH and other Federal Center programs.
Provide a mechanism for data science education relevant to neurodegenerative disease research.
Facilitate career development to increase diversity of leadership positions within the Center.
Education and outreach activities aligned with Clinical Core for recruitment of diverse populations.”
总结/摘要-研究教育部分(REC)
亚利桑那州ADRC REC培训计划涉及国家阿尔茨海默病项目的目标和目的
法案(NACA)“到2025年预防和有效治疗阿尔茨海默病和相关痴呆症(AD/ADRD)”。
它符合NIH AD和ADRD研究峰会的建议,ADRC的首要主题(血液-
基于生物标志物(“BBB”)的AD/ADRD的诊断、临床前研究和预防,
合作模式,以及我们致力于帮助开发下一代AD/ADRD研究人员,
包括来自不同背景的人。我们提出了一个个性化的战略,以吸引和促进初级
教师和研究人员进行创新的综合AD/ADRD研究是临床相关的,
理论上有效,科学上可重复,包括代表性不足的群体。为了弥补
学术培训,AZ ADRC REC将推进必要的技能发展,以取得成功,
21世纪世纪团队科学、领导力、人事和财务管理以及协作伦理研究;
进一步发展和应用他们的专业知识和技能,以对抗AD和ADRD;并利用我们的
计划和少数民族老龄化研究资源中心(RCMAR)合作伙伴关系,以推进研究事业
以及涉及西班牙裔、美洲原住民和其他代表性不足的社区的研究。
为了建立未来AD/ ADRD研究人员的管道,我们提出了一个经验依赖型导师制
AZ ADRC REC补充NIH / NIA博士后,博士前和博士后培训计划的战略
本科研究员和跨越种族,文化和专业的多样性。实现这些目标的战略
目标包括:具体目标1:21世纪团队科学的个性化AD/ADRD研究职业计划;
具体目标2:世纪变革速度下的领导和道德
阿尔茨海默氏症研究未来的职业管道。这些努力的结果将推动整体
NIH/NIA阿尔茨海默病研究中心RFA-AG-20-004中阐述的ADRC目标包括:
“创造一个动态的教育环境,支持颠覆性和变革性的研究。
加速跨疾病谱的转化研究。
在NIH和其他联邦中心项目中展示科学上富有成效的互动。
提供与神经退行性疾病研究相关的数据科学教育机制。
促进职业发展,增加中心内领导职位的多样性。
“与临床核心相一致的教育和推广活动,以招募不同的人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERTA EILEEN BRINTON其他文献
ROBERTA EILEEN BRINTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERTA EILEEN BRINTON', 18)}}的其他基金
Translational Research in Alzheimer's Disease and related Dementias (TRADD)
阿尔茨海默病和相关痴呆症的转化研究 (TRADD)
- 批准号:
10709167 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
Allopregnanolone 的新型鼻内制剂,一种阿尔茨海默病的再生疗法
- 批准号:
10698555 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
PhytoSERM 预防更年期相关脑代谢和认知能力下降的功效:双盲、随机、安慰剂对照 2 期临床试验
- 批准号:
10560591 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
PhytoSERM 针对更年期潮热和持续大脑健康
- 批准号:
10547639 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
PhytoSERM 预防更年期相关脑代谢和认知能力下降的功效:双盲、随机、安慰剂对照 2 期临床试验
- 批准号:
10344556 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
PhytoSERM 针对更年期潮热和持续大脑健康
- 批准号:
10707107 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Regulatory and Human Study Operations (RHSO) Core C
监管和人体研究运营 (RHSO) 核心 C
- 批准号:
10689308 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Regulatory and Human Study Operations (RHSO) Core C
监管和人体研究运营 (RHSO) 核心 C
- 批准号:
10491851 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Regulatory and Human Study Operations (RHSO) Core C
监管和人体研究运营 (RHSO) 核心 C
- 批准号:
10270190 - 财政年份:2021
- 资助金额:
$ 19.07万 - 项目类别:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
本科生为美洲印第安人神经科学家的新兴研究做好准备
- 批准号:
10199069 - 财政年份:2019
- 资助金额:
$ 19.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant